nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—SLC22A1—Latanoprost—glaucoma	0.12	0.164	CbGbCtD
Disopyramide—CHRM3—Carbachol—glaucoma	0.0964	0.132	CbGbCtD
Disopyramide—CHRM3—Pilocarpine—glaucoma	0.0896	0.122	CbGbCtD
Disopyramide—CHRM1—Carbachol—glaucoma	0.0839	0.115	CbGbCtD
Disopyramide—CHRM1—Pilocarpine—glaucoma	0.078	0.106	CbGbCtD
Disopyramide—CHRM2—Carbachol—glaucoma	0.0773	0.106	CbGbCtD
Disopyramide—CHRM2—Pilocarpine—glaucoma	0.0719	0.0982	CbGbCtD
Disopyramide—SLC22A1—Clonidine—glaucoma	0.0443	0.0606	CbGbCtD
Disopyramide—CYP3A4—Pilocarpine—glaucoma	0.0167	0.0228	CbGbCtD
Disopyramide—CYP3A4—Brinzolamide—glaucoma	0.0131	0.0179	CbGbCtD
Disopyramide—CYP3A4—Dorzolamide—glaucoma	0.0126	0.0173	CbGbCtD
Disopyramide—CYP3A4—Methazolamide—glaucoma	0.0113	0.0154	CbGbCtD
Disopyramide—CYP3A4—Acetazolamide—glaucoma	0.009	0.0123	CbGbCtD
Disopyramide—CYP3A4—Clonidine—glaucoma	0.00814	0.0111	CbGbCtD
Disopyramide—Confusional state—Pilocarpine—glaucoma	0.000248	0.00104	CcSEcCtD
Disopyramide—Arrhythmia—Clonidine—glaucoma	0.000247	0.00104	CcSEcCtD
Disopyramide—Decreased appetite—Acetazolamide—glaucoma	0.000247	0.00104	CcSEcCtD
Disopyramide—Insomnia—Brimonidine—glaucoma	0.000247	0.00104	CcSEcCtD
Disopyramide—Oedema—Pilocarpine—glaucoma	0.000246	0.00103	CcSEcCtD
Disopyramide—Bradycardia—Betaxolol—glaucoma	0.000245	0.00103	CcSEcCtD
Disopyramide—Fatigue—Acetazolamide—glaucoma	0.000245	0.00103	CcSEcCtD
Disopyramide—Paraesthesia—Brimonidine—glaucoma	0.000245	0.00103	CcSEcCtD
Disopyramide—Nausea—Methazolamide—glaucoma	0.000244	0.00102	CcSEcCtD
Disopyramide—Hypotension—Dorzolamide—glaucoma	0.000244	0.00102	CcSEcCtD
Disopyramide—Dyspnoea—Brimonidine—glaucoma	0.000243	0.00102	CcSEcCtD
Disopyramide—Somnolence—Brimonidine—glaucoma	0.000243	0.00102	CcSEcCtD
Disopyramide—Hypotension—Travoprost—glaucoma	0.000243	0.00102	CcSEcCtD
Disopyramide—Shock—Pilocarpine—glaucoma	0.000242	0.00102	CcSEcCtD
Disopyramide—Thrombocytopenia—Pilocarpine—glaucoma	0.000241	0.00101	CcSEcCtD
Disopyramide—Dyspepsia—Brimonidine—glaucoma	0.00024	0.00101	CcSEcCtD
Disopyramide—Hypoaesthesia—Betaxolol—glaucoma	0.00024	0.00101	CcSEcCtD
Disopyramide—Hypotension—Brinzolamide—glaucoma	0.00024	0.00101	CcSEcCtD
Disopyramide—Hyperhidrosis—Pilocarpine—glaucoma	0.000238	0.001	CcSEcCtD
Disopyramide—Tension—Clonidine—glaucoma	0.000237	0.000993	CcSEcCtD
Disopyramide—Insomnia—Dorzolamide—glaucoma	0.000236	0.00099	CcSEcCtD
Disopyramide—Fatigue—Brimonidine—glaucoma	0.000235	0.000988	CcSEcCtD
Disopyramide—Anorexia—Pilocarpine—glaucoma	0.000235	0.000986	CcSEcCtD
Disopyramide—Feeling abnormal—Acetazolamide—glaucoma	0.000234	0.000984	CcSEcCtD
Disopyramide—Nervousness—Clonidine—glaucoma	0.000234	0.000983	CcSEcCtD
Disopyramide—Paraesthesia—Dorzolamide—glaucoma	0.000234	0.000983	CcSEcCtD
Disopyramide—Pain—Brimonidine—glaucoma	0.000233	0.00098	CcSEcCtD
Disopyramide—Dyspnoea—Dorzolamide—glaucoma	0.000232	0.000976	CcSEcCtD
Disopyramide—Insomnia—Brinzolamide—glaucoma	0.000232	0.000973	CcSEcCtD
Disopyramide—Somnolence—Dorzolamide—glaucoma	0.000232	0.000973	CcSEcCtD
Disopyramide—Dyspnoea—Travoprost—glaucoma	0.000231	0.000972	CcSEcCtD
Disopyramide—Hypotension—Pilocarpine—glaucoma	0.00023	0.000966	CcSEcCtD
Disopyramide—Paraesthesia—Brinzolamide—glaucoma	0.00023	0.000966	CcSEcCtD
Disopyramide—Dysuria—Timolol—glaucoma	0.00023	0.000966	CcSEcCtD
Disopyramide—Dyspepsia—Dorzolamide—glaucoma	0.000229	0.000963	CcSEcCtD
Disopyramide—Dyspnoea—Brinzolamide—glaucoma	0.000229	0.000959	CcSEcCtD
Disopyramide—Dyspepsia—Travoprost—glaucoma	0.000229	0.000959	CcSEcCtD
Disopyramide—Asthenia—Apraclonidine—glaucoma	0.000228	0.000958	CcSEcCtD
Disopyramide—Somnolence—Brinzolamide—glaucoma	0.000228	0.000957	CcSEcCtD
Disopyramide—Vision blurred—Clonidine—glaucoma	0.000227	0.000954	CcSEcCtD
Disopyramide—Decreased appetite—Dorzolamide—glaucoma	0.000227	0.000951	CcSEcCtD
Disopyramide—Erectile dysfunction—Timolol—glaucoma	0.000227	0.000951	CcSEcCtD
Disopyramide—Urticaria—Acetazolamide—glaucoma	0.000226	0.000949	CcSEcCtD
Disopyramide—Dyspepsia—Brinzolamide—glaucoma	0.000226	0.000947	CcSEcCtD
Disopyramide—Pruritus—Apraclonidine—glaucoma	0.000225	0.000944	CcSEcCtD
Disopyramide—Body temperature increased—Acetazolamide—glaucoma	0.000225	0.000944	CcSEcCtD
Disopyramide—Fatigue—Dorzolamide—glaucoma	0.000225	0.000944	CcSEcCtD
Disopyramide—Fatigue—Travoprost—glaucoma	0.000224	0.00094	CcSEcCtD
Disopyramide—Ill-defined disorder—Clonidine—glaucoma	0.000224	0.000939	CcSEcCtD
Disopyramide—Pain—Dorzolamide—glaucoma	0.000223	0.000936	CcSEcCtD
Disopyramide—Insomnia—Pilocarpine—glaucoma	0.000223	0.000935	CcSEcCtD
Disopyramide—Decreased appetite—Brinzolamide—glaucoma	0.000223	0.000935	CcSEcCtD
Disopyramide—Pain—Travoprost—glaucoma	0.000222	0.000932	CcSEcCtD
Disopyramide—Constipation—Travoprost—glaucoma	0.000222	0.000932	CcSEcCtD
Disopyramide—Paraesthesia—Pilocarpine—glaucoma	0.000221	0.000929	CcSEcCtD
Disopyramide—Asthenia—Bimatoprost—glaucoma	0.000221	0.000929	CcSEcCtD
Disopyramide—Fatigue—Brinzolamide—glaucoma	0.000221	0.000928	CcSEcCtD
Disopyramide—Angioedema—Clonidine—glaucoma	0.00022	0.000925	CcSEcCtD
Disopyramide—Dyspnoea—Pilocarpine—glaucoma	0.00022	0.000922	CcSEcCtD
Disopyramide—Pain—Brinzolamide—glaucoma	0.000219	0.00092	CcSEcCtD
Disopyramide—Somnolence—Pilocarpine—glaucoma	0.000219	0.000919	CcSEcCtD
Disopyramide—Depression—Timolol—glaucoma	0.000219	0.000918	CcSEcCtD
Disopyramide—Pruritus—Bimatoprost—glaucoma	0.000218	0.000916	CcSEcCtD
Disopyramide—Diarrhoea—Apraclonidine—glaucoma	0.000218	0.000913	CcSEcCtD
Disopyramide—Malaise—Clonidine—glaucoma	0.000217	0.000913	CcSEcCtD
Disopyramide—Dyspepsia—Pilocarpine—glaucoma	0.000217	0.00091	CcSEcCtD
Disopyramide—Syncope—Clonidine—glaucoma	0.000216	0.000908	CcSEcCtD
Disopyramide—Arrhythmia—Betaxolol—glaucoma	0.000215	0.000904	CcSEcCtD
Disopyramide—Feeling abnormal—Dorzolamide—glaucoma	0.000215	0.000902	CcSEcCtD
Disopyramide—Decreased appetite—Pilocarpine—glaucoma	0.000214	0.000899	CcSEcCtD
Disopyramide—Feeling abnormal—Travoprost—glaucoma	0.000214	0.000898	CcSEcCtD
Disopyramide—Loss of consciousness—Clonidine—glaucoma	0.000212	0.000889	CcSEcCtD
Disopyramide—Feeling abnormal—Brinzolamide—glaucoma	0.000211	0.000887	CcSEcCtD
Disopyramide—Pain—Pilocarpine—glaucoma	0.000211	0.000884	CcSEcCtD
Disopyramide—Constipation—Pilocarpine—glaucoma	0.000211	0.000884	CcSEcCtD
Disopyramide—Dizziness—Apraclonidine—glaucoma	0.00021	0.000883	CcSEcCtD
Disopyramide—Urticaria—Dorzolamide—glaucoma	0.000207	0.00087	CcSEcCtD
Disopyramide—Body temperature increased—Dorzolamide—glaucoma	0.000206	0.000865	CcSEcCtD
Disopyramide—Tension—Betaxolol—glaucoma	0.000206	0.000865	CcSEcCtD
Disopyramide—Dysgeusia—Betaxolol—glaucoma	0.000206	0.000863	CcSEcCtD
Disopyramide—Chest pain—Clonidine—glaucoma	0.000205	0.000862	CcSEcCtD
Disopyramide—Agranulocytosis—Timolol—glaucoma	0.000205	0.00086	CcSEcCtD
Disopyramide—Asthenia—Acetazolamide—glaucoma	0.000204	0.000857	CcSEcCtD
Disopyramide—Dizziness—Bimatoprost—glaucoma	0.000204	0.000856	CcSEcCtD
Disopyramide—Nervousness—Betaxolol—glaucoma	0.000204	0.000856	CcSEcCtD
Disopyramide—Urticaria—Brinzolamide—glaucoma	0.000204	0.000855	CcSEcCtD
Disopyramide—Feeling abnormal—Pilocarpine—glaucoma	0.000203	0.000852	CcSEcCtD
Disopyramide—Discomfort—Clonidine—glaucoma	0.000203	0.000851	CcSEcCtD
Disopyramide—Vomiting—Apraclonidine—glaucoma	0.000202	0.000849	CcSEcCtD
Disopyramide—Dry mouth—Clonidine—glaucoma	0.000201	0.000843	CcSEcCtD
Disopyramide—Bradycardia—Timolol—glaucoma	0.0002	0.000842	CcSEcCtD
Disopyramide—Dermatitis—Apraclonidine—glaucoma	0.0002	0.000841	CcSEcCtD
Disopyramide—Headache—Apraclonidine—glaucoma	0.000199	0.000836	CcSEcCtD
Disopyramide—Confusional state—Clonidine—glaucoma	0.000198	0.000833	CcSEcCtD
Disopyramide—Vision blurred—Betaxolol—glaucoma	0.000198	0.00083	CcSEcCtD
Disopyramide—Oedema—Clonidine—glaucoma	0.000197	0.000826	CcSEcCtD
Disopyramide—Asthenia—Brimonidine—glaucoma	0.000196	0.000822	CcSEcCtD
Disopyramide—Body temperature increased—Pilocarpine—glaucoma	0.000195	0.000818	CcSEcCtD
Disopyramide—Ill-defined disorder—Betaxolol—glaucoma	0.000195	0.000817	CcSEcCtD
Disopyramide—Diarrhoea—Acetazolamide—glaucoma	0.000195	0.000817	CcSEcCtD
Disopyramide—Rash—Bimatoprost—glaucoma	0.000194	0.000816	CcSEcCtD
Disopyramide—Dermatitis—Bimatoprost—glaucoma	0.000194	0.000815	CcSEcCtD
Disopyramide—Shock—Clonidine—glaucoma	0.000194	0.000813	CcSEcCtD
Disopyramide—Pruritus—Brimonidine—glaucoma	0.000193	0.000811	CcSEcCtD
Disopyramide—Headache—Bimatoprost—glaucoma	0.000193	0.000811	CcSEcCtD
Disopyramide—Thrombocytopenia—Clonidine—glaucoma	0.000193	0.000809	CcSEcCtD
Disopyramide—Skin disorder—Clonidine—glaucoma	0.000191	0.000802	CcSEcCtD
Disopyramide—Hyperhidrosis—Clonidine—glaucoma	0.00019	0.000798	CcSEcCtD
Disopyramide—Malaise—Betaxolol—glaucoma	0.000189	0.000795	CcSEcCtD
Disopyramide—Nausea—Apraclonidine—glaucoma	0.000189	0.000793	CcSEcCtD
Disopyramide—Vertigo—Betaxolol—glaucoma	0.000189	0.000792	CcSEcCtD
Disopyramide—Syncope—Betaxolol—glaucoma	0.000188	0.00079	CcSEcCtD
Disopyramide—Dizziness—Acetazolamide—glaucoma	0.000188	0.00079	CcSEcCtD
Disopyramide—Anorexia—Clonidine—glaucoma	0.000188	0.000787	CcSEcCtD
Disopyramide—Asthenia—Dorzolamide—glaucoma	0.000187	0.000785	CcSEcCtD
Disopyramide—Asthenia—Travoprost—glaucoma	0.000186	0.000782	CcSEcCtD
Disopyramide—Pruritus—Dorzolamide—glaucoma	0.000184	0.000774	CcSEcCtD
Disopyramide—Loss of consciousness—Betaxolol—glaucoma	0.000184	0.000774	CcSEcCtD
Disopyramide—Asthenia—Brinzolamide—glaucoma	0.000184	0.000772	CcSEcCtD
Disopyramide—Hypotension—Clonidine—glaucoma	0.000184	0.000772	CcSEcCtD
Disopyramide—Pruritus—Travoprost—glaucoma	0.000184	0.000771	CcSEcCtD
Disopyramide—Nausea—Bimatoprost—glaucoma	0.000183	0.000769	CcSEcCtD
Disopyramide—Pruritus—Brinzolamide—glaucoma	0.000181	0.000761	CcSEcCtD
Disopyramide—Vomiting—Acetazolamide—glaucoma	0.000181	0.000759	CcSEcCtD
Disopyramide—Dizziness—Brimonidine—glaucoma	0.000181	0.000758	CcSEcCtD
Disopyramide—Chest pain—Betaxolol—glaucoma	0.000179	0.00075	CcSEcCtD
Disopyramide—Diarrhoea—Dorzolamide—glaucoma	0.000178	0.000749	CcSEcCtD
Disopyramide—Headache—Acetazolamide—glaucoma	0.000178	0.000748	CcSEcCtD
Disopyramide—Insomnia—Clonidine—glaucoma	0.000178	0.000747	CcSEcCtD
Disopyramide—Diarrhoea—Travoprost—glaucoma	0.000178	0.000746	CcSEcCtD
Disopyramide—Asthenia—Pilocarpine—glaucoma	0.000177	0.000742	CcSEcCtD
Disopyramide—Paraesthesia—Clonidine—glaucoma	0.000177	0.000742	CcSEcCtD
Disopyramide—Discomfort—Betaxolol—glaucoma	0.000177	0.000741	CcSEcCtD
Disopyramide—Arrhythmia—Timolol—glaucoma	0.000176	0.000739	CcSEcCtD
Disopyramide—Dyspnoea—Clonidine—glaucoma	0.000175	0.000736	CcSEcCtD
Disopyramide—Diarrhoea—Brinzolamide—glaucoma	0.000175	0.000736	CcSEcCtD
Disopyramide—Somnolence—Clonidine—glaucoma	0.000175	0.000734	CcSEcCtD
Disopyramide—Dry mouth—Betaxolol—glaucoma	0.000175	0.000734	CcSEcCtD
Disopyramide—Pruritus—Pilocarpine—glaucoma	0.000174	0.000732	CcSEcCtD
Disopyramide—Confusional state—Betaxolol—glaucoma	0.000173	0.000725	CcSEcCtD
Disopyramide—Dizziness—Dorzolamide—glaucoma	0.000172	0.000724	CcSEcCtD
Disopyramide—Rash—Brimonidine—glaucoma	0.000172	0.000723	CcSEcCtD
Disopyramide—Dermatitis—Brimonidine—glaucoma	0.000172	0.000722	CcSEcCtD
Disopyramide—Dizziness—Travoprost—glaucoma	0.000172	0.000721	CcSEcCtD
Disopyramide—Oedema—Betaxolol—glaucoma	0.000171	0.000719	CcSEcCtD
Disopyramide—Headache—Brimonidine—glaucoma	0.000171	0.000718	CcSEcCtD
Disopyramide—Decreased appetite—Clonidine—glaucoma	0.000171	0.000718	CcSEcCtD
Disopyramide—Fatigue—Clonidine—glaucoma	0.00017	0.000712	CcSEcCtD
Disopyramide—Dizziness—Brinzolamide—glaucoma	0.000169	0.000712	CcSEcCtD
Disopyramide—Nausea—Acetazolamide—glaucoma	0.000169	0.000709	CcSEcCtD
Disopyramide—Diarrhoea—Pilocarpine—glaucoma	0.000169	0.000708	CcSEcCtD
Disopyramide—Shock—Betaxolol—glaucoma	0.000169	0.000707	CcSEcCtD
Disopyramide—Tension—Timolol—glaucoma	0.000168	0.000706	CcSEcCtD
Disopyramide—Pain—Clonidine—glaucoma	0.000168	0.000706	CcSEcCtD
Disopyramide—Constipation—Clonidine—glaucoma	0.000168	0.000706	CcSEcCtD
Disopyramide—Dysgeusia—Timolol—glaucoma	0.000168	0.000705	CcSEcCtD
Disopyramide—Thrombocytopenia—Betaxolol—glaucoma	0.000168	0.000704	CcSEcCtD
Disopyramide—Nervousness—Timolol—glaucoma	0.000167	0.000699	CcSEcCtD
Disopyramide—Skin disorder—Betaxolol—glaucoma	0.000166	0.000698	CcSEcCtD
Disopyramide—Vomiting—Dorzolamide—glaucoma	0.000166	0.000696	CcSEcCtD
Disopyramide—Hyperhidrosis—Betaxolol—glaucoma	0.000166	0.000695	CcSEcCtD
Disopyramide—Rash—Dorzolamide—glaucoma	0.000164	0.00069	CcSEcCtD
Disopyramide—Dermatitis—Dorzolamide—glaucoma	0.000164	0.000689	CcSEcCtD
Disopyramide—Rash—Travoprost—glaucoma	0.000164	0.000687	CcSEcCtD
Disopyramide—Dermatitis—Travoprost—glaucoma	0.000164	0.000687	CcSEcCtD
Disopyramide—Headache—Dorzolamide—glaucoma	0.000163	0.000686	CcSEcCtD
Disopyramide—Anorexia—Betaxolol—glaucoma	0.000163	0.000685	CcSEcCtD
Disopyramide—Vomiting—Brinzolamide—glaucoma	0.000163	0.000684	CcSEcCtD
Disopyramide—Dizziness—Pilocarpine—glaucoma	0.000163	0.000684	CcSEcCtD
Disopyramide—Headache—Travoprost—glaucoma	0.000163	0.000683	CcSEcCtD
Disopyramide—Nausea—Brimonidine—glaucoma	0.000162	0.000681	CcSEcCtD
Disopyramide—Feeling abnormal—Clonidine—glaucoma	0.000162	0.000681	CcSEcCtD
Disopyramide—Rash—Brinzolamide—glaucoma	0.000162	0.000678	CcSEcCtD
Disopyramide—Vision blurred—Timolol—glaucoma	0.000162	0.000678	CcSEcCtD
Disopyramide—Dermatitis—Brinzolamide—glaucoma	0.000161	0.000678	CcSEcCtD
Disopyramide—Headache—Brinzolamide—glaucoma	0.000161	0.000674	CcSEcCtD
Disopyramide—Hypotension—Betaxolol—glaucoma	0.00016	0.000672	CcSEcCtD
Disopyramide—Angioedema—Timolol—glaucoma	0.000157	0.000658	CcSEcCtD
Disopyramide—Vomiting—Pilocarpine—glaucoma	0.000157	0.000658	CcSEcCtD
Disopyramide—Urticaria—Clonidine—glaucoma	0.000156	0.000656	CcSEcCtD
Disopyramide—Body temperature increased—Clonidine—glaucoma	0.000156	0.000653	CcSEcCtD
Disopyramide—Rash—Pilocarpine—glaucoma	0.000155	0.000652	CcSEcCtD
Disopyramide—Dermatitis—Pilocarpine—glaucoma	0.000155	0.000651	CcSEcCtD
Disopyramide—Insomnia—Betaxolol—glaucoma	0.000155	0.00065	CcSEcCtD
Disopyramide—Nausea—Dorzolamide—glaucoma	0.000155	0.00065	CcSEcCtD
Disopyramide—Headache—Pilocarpine—glaucoma	0.000154	0.000648	CcSEcCtD
Disopyramide—Nausea—Travoprost—glaucoma	0.000154	0.000647	CcSEcCtD
Disopyramide—Vertigo—Timolol—glaucoma	0.000154	0.000647	CcSEcCtD
Disopyramide—Paraesthesia—Betaxolol—glaucoma	0.000154	0.000646	CcSEcCtD
Disopyramide—Syncope—Timolol—glaucoma	0.000154	0.000645	CcSEcCtD
Disopyramide—Dyspnoea—Betaxolol—glaucoma	0.000153	0.000641	CcSEcCtD
Disopyramide—Nausea—Brinzolamide—glaucoma	0.000152	0.000639	CcSEcCtD
Disopyramide—Dyspepsia—Betaxolol—glaucoma	0.000151	0.000633	CcSEcCtD
Disopyramide—Loss of consciousness—Timolol—glaucoma	0.000151	0.000633	CcSEcCtD
Disopyramide—Decreased appetite—Betaxolol—glaucoma	0.000149	0.000625	CcSEcCtD
Disopyramide—Fatigue—Betaxolol—glaucoma	0.000148	0.00062	CcSEcCtD
Disopyramide—Constipation—Betaxolol—glaucoma	0.000146	0.000615	CcSEcCtD
Disopyramide—Pain—Betaxolol—glaucoma	0.000146	0.000615	CcSEcCtD
Disopyramide—Nausea—Pilocarpine—glaucoma	0.000146	0.000614	CcSEcCtD
Disopyramide—Chest pain—Timolol—glaucoma	0.000146	0.000613	CcSEcCtD
Disopyramide—Discomfort—Timolol—glaucoma	0.000144	0.000605	CcSEcCtD
Disopyramide—Dry mouth—Timolol—glaucoma	0.000143	0.000599	CcSEcCtD
Disopyramide—Asthenia—Clonidine—glaucoma	0.000141	0.000593	CcSEcCtD
Disopyramide—Feeling abnormal—Betaxolol—glaucoma	0.000141	0.000593	CcSEcCtD
Disopyramide—Confusional state—Timolol—glaucoma	0.000141	0.000592	CcSEcCtD
Disopyramide—Oedema—Timolol—glaucoma	0.00014	0.000587	CcSEcCtD
Disopyramide—Pruritus—Clonidine—glaucoma	0.000139	0.000584	CcSEcCtD
Disopyramide—Shock—Timolol—glaucoma	0.000138	0.000578	CcSEcCtD
Disopyramide—Urticaria—Betaxolol—glaucoma	0.000136	0.000571	CcSEcCtD
Disopyramide—Skin disorder—Timolol—glaucoma	0.000136	0.000571	CcSEcCtD
Disopyramide—Body temperature increased—Betaxolol—glaucoma	0.000135	0.000568	CcSEcCtD
Disopyramide—Hyperhidrosis—Timolol—glaucoma	0.000135	0.000568	CcSEcCtD
Disopyramide—Diarrhoea—Clonidine—glaucoma	0.000135	0.000565	CcSEcCtD
Disopyramide—Anorexia—Timolol—glaucoma	0.000133	0.00056	CcSEcCtD
Disopyramide—Hypotension—Timolol—glaucoma	0.000131	0.000549	CcSEcCtD
Disopyramide—Dizziness—Clonidine—glaucoma	0.00013	0.000546	CcSEcCtD
Disopyramide—Insomnia—Timolol—glaucoma	0.000127	0.000531	CcSEcCtD
Disopyramide—Paraesthesia—Timolol—glaucoma	0.000126	0.000527	CcSEcCtD
Disopyramide—Vomiting—Clonidine—glaucoma	0.000125	0.000525	CcSEcCtD
Disopyramide—Dyspnoea—Timolol—glaucoma	0.000125	0.000524	CcSEcCtD
Disopyramide—Somnolence—Timolol—glaucoma	0.000124	0.000522	CcSEcCtD
Disopyramide—Rash—Clonidine—glaucoma	0.000124	0.000521	CcSEcCtD
Disopyramide—Dermatitis—Clonidine—glaucoma	0.000124	0.00052	CcSEcCtD
Disopyramide—Headache—Clonidine—glaucoma	0.000123	0.000517	CcSEcCtD
Disopyramide—Dyspepsia—Timolol—glaucoma	0.000123	0.000517	CcSEcCtD
Disopyramide—Asthenia—Betaxolol—glaucoma	0.000123	0.000516	CcSEcCtD
Disopyramide—CHRM2—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000122	0.0041	CbGpPWpGaD
Disopyramide—Decreased appetite—Timolol—glaucoma	0.000122	0.000511	CcSEcCtD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000122	0.00409	CbGpPWpGaD
Disopyramide—Pruritus—Betaxolol—glaucoma	0.000121	0.000509	CcSEcCtD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—PEX19—glaucoma	0.000121	0.00407	CbGpPWpGaD
Disopyramide—Fatigue—Timolol—glaucoma	0.000121	0.000506	CcSEcCtD
Disopyramide—Pain—Timolol—glaucoma	0.00012	0.000502	CcSEcCtD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000117	0.00395	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000117	0.00395	CbGpPWpGaD
Disopyramide—Diarrhoea—Betaxolol—glaucoma	0.000117	0.000492	CcSEcCtD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000117	0.00394	CbGpPWpGaD
Disopyramide—Nausea—Clonidine—glaucoma	0.000117	0.000491	CcSEcCtD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000117	0.00393	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000116	0.0039	CbGpPWpGaD
Disopyramide—Feeling abnormal—Timolol—glaucoma	0.000115	0.000484	CcSEcCtD
Disopyramide—SLC22A2—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000115	0.00387	CbGpPWpGaD
Disopyramide—Dizziness—Betaxolol—glaucoma	0.000113	0.000475	CcSEcCtD
Disopyramide—Urticaria—Timolol—glaucoma	0.000111	0.000467	CcSEcCtD
Disopyramide—Body temperature increased—Timolol—glaucoma	0.000111	0.000464	CcSEcCtD
Disopyramide—Vomiting—Betaxolol—glaucoma	0.000109	0.000457	CcSEcCtD
Disopyramide—SLC22A2—Neuronal System—SLC6A13—glaucoma	0.000109	0.00366	CbGpPWpGaD
Disopyramide—Rash—Betaxolol—glaucoma	0.000108	0.000453	CcSEcCtD
Disopyramide—Dermatitis—Betaxolol—glaucoma	0.000108	0.000453	CcSEcCtD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—NGF—glaucoma	0.000108	0.00363	CbGpPWpGaD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000107	0.00361	CbGpPWpGaD
Disopyramide—Headache—Betaxolol—glaucoma	0.000107	0.00045	CcSEcCtD
Disopyramide—SLC22A1—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000107	0.00361	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—NCK2—glaucoma	0.000106	0.00358	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000106	0.00356	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000105	0.00355	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000104	0.00351	CbGpPWpGaD
Disopyramide—SLC22A2—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000104	0.00349	CbGpPWpGaD
Disopyramide—Nausea—Betaxolol—glaucoma	0.000102	0.000427	CcSEcCtD
Disopyramide—SLC22A1—Neuronal System—SLC6A13—glaucoma	0.000101	0.00341	CbGpPWpGaD
Disopyramide—Asthenia—Timolol—glaucoma	0.0001	0.000421	CcSEcCtD
Disopyramide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.0001	0.00336	CbGpPWpGaD
Disopyramide—Pruritus—Timolol—glaucoma	9.9e-05	0.000416	CcSEcCtD
Disopyramide—SLC22A1—Transmission across Chemical Synapses—SLC6A1—glaucoma	9.68e-05	0.00326	CbGpPWpGaD
Disopyramide—Diarrhoea—Timolol—glaucoma	9.57e-05	0.000402	CcSEcCtD
Disopyramide—Dizziness—Timolol—glaucoma	9.25e-05	0.000388	CcSEcCtD
Disopyramide—CHRM1—GPCR ligand binding—OPN4—glaucoma	8.94e-05	0.00301	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—OPN4—glaucoma	8.91e-05	0.003	CbGpPWpGaD
Disopyramide—Vomiting—Timolol—glaucoma	8.9e-05	0.000373	CcSEcCtD
Disopyramide—Rash—Timolol—glaucoma	8.82e-05	0.00037	CcSEcCtD
Disopyramide—CHRM2—GPCR ligand binding—OPN4—glaucoma	8.82e-05	0.00297	CbGpPWpGaD
Disopyramide—Dermatitis—Timolol—glaucoma	8.81e-05	0.00037	CcSEcCtD
Disopyramide—Headache—Timolol—glaucoma	8.77e-05	0.000368	CcSEcCtD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—SLC4A4—glaucoma	8.76e-05	0.00295	CbGpPWpGaD
Disopyramide—SLC22A2—SLC-mediated transmembrane transport—SLC6A1—glaucoma	8.42e-05	0.00283	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—NTRK2—glaucoma	8.4e-05	0.00283	CbGpPWpGaD
Disopyramide—KCND2—Circadian rythm related genes—TP53—glaucoma	8.32e-05	0.0028	CbGpPWpGaD
Disopyramide—Nausea—Timolol—glaucoma	8.31e-05	0.000349	CcSEcCtD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—SLC4A4—glaucoma	8.16e-05	0.00275	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—PTGFR—glaucoma	8.05e-05	0.00271	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—PTGFR—glaucoma	8.02e-05	0.0027	CbGpPWpGaD
Disopyramide—SLC22A2—Neuronal System—SLC6A1—glaucoma	7.95e-05	0.00268	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—PTGFR—glaucoma	7.94e-05	0.00267	CbGpPWpGaD
Disopyramide—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	7.85e-05	0.00264	CbGpPWpGaD
Disopyramide—SLC22A1—SLC-mediated transmembrane transport—SLC6A1—glaucoma	7.84e-05	0.00264	CbGpPWpGaD
Disopyramide—SLC22A1—Neuronal System—SLC6A1—glaucoma	7.41e-05	0.0025	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—NARFL—glaucoma	7.14e-05	0.0024	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—CA5A—glaucoma	7.14e-05	0.0024	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—PAX6—glaucoma	6.89e-05	0.00232	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—NARFL—glaucoma	6.66e-05	0.00224	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CA5A—glaucoma	6.66e-05	0.00224	CbGpPWpGaD
Disopyramide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	6.35e-05	0.00214	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—BDNF—glaucoma	6.27e-05	0.00211	CbGpPWpGaD
Disopyramide—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	6.26e-05	0.00211	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—NARFL—glaucoma	6.15e-05	0.00207	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CA5A—glaucoma	6.15e-05	0.00207	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—IL1A—glaucoma	6.02e-05	0.00203	CbGpPWpGaD
Disopyramide—CHRM1—Circadian rythm related genes—NGFR—glaucoma	5.96e-05	0.00201	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—SLC6A13—glaucoma	5.84e-05	0.00197	CbGpPWpGaD
Disopyramide—CHRM1—Circadian rythm related genes—NTRK1—glaucoma	5.66e-05	0.00191	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—NGF—glaucoma	5.56e-05	0.00187	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—NR3C1—glaucoma	5.54e-05	0.00186	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—SLC6A13—glaucoma	5.45e-05	0.00183	CbGpPWpGaD
Disopyramide—CHRM1—G alpha (q) signalling events—EDN1—glaucoma	5.3e-05	0.00179	CbGpPWpGaD
Disopyramide—CHRM3—G alpha (q) signalling events—EDN1—glaucoma	5.29e-05	0.00178	CbGpPWpGaD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—VEGFA—glaucoma	5.15e-05	0.00173	CbGpPWpGaD
Disopyramide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	5.14e-05	0.00173	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—OPN4—glaucoma	5.05e-05	0.0017	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—OPN4—glaucoma	5.03e-05	0.00169	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—OPN4—glaucoma	4.99e-05	0.00168	CbGpPWpGaD
Disopyramide—CHRM1—Regulation of Actin Cytoskeleton—FN1—glaucoma	4.88e-05	0.00164	CbGpPWpGaD
Disopyramide—CHRM3—Regulation of Actin Cytoskeleton—FN1—glaucoma	4.86e-05	0.00164	CbGpPWpGaD
Disopyramide—CHRM2—Regulation of Actin Cytoskeleton—FN1—glaucoma	4.82e-05	0.00162	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	4.74e-05	0.0016	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	4.73e-05	0.00159	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—OPN4—glaucoma	4.59e-05	0.00154	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—OPN4—glaucoma	4.57e-05	0.00154	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—PTGFR—glaucoma	4.55e-05	0.00153	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—PTGFR—glaucoma	4.53e-05	0.00153	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—OPN4—glaucoma	4.53e-05	0.00152	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—PTGFR—glaucoma	4.49e-05	0.00151	CbGpPWpGaD
Disopyramide—CHRM1—Circadian rythm related genes—FAS—glaucoma	4.44e-05	0.00149	CbGpPWpGaD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—TNF—glaucoma	4.42e-05	0.00149	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—SLC6A1—glaucoma	4.28e-05	0.00144	CbGpPWpGaD
Disopyramide—SCN5A—Axon guidance—MMP2—glaucoma	4.25e-05	0.00143	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—PTGFR—glaucoma	4.13e-05	0.00139	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—PTGFR—glaucoma	4.12e-05	0.00139	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—PTGFR—glaucoma	4.08e-05	0.00137	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—SMO—glaucoma	4.06e-05	0.00137	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—SMO—glaucoma	4.04e-05	0.00136	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—SMO—glaucoma	4.01e-05	0.00135	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—SLC6A1—glaucoma	3.99e-05	0.00134	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—LRP12—glaucoma	3.91e-05	0.00132	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—LRP12—glaucoma	3.9e-05	0.00131	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—LRP12—glaucoma	3.86e-05	0.0013	CbGpPWpGaD
Disopyramide—CHRM2—G alpha (i) signalling events—C3—glaucoma	3.81e-05	0.00128	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	3.51e-05	0.00118	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	3.5e-05	0.00118	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—CA1—glaucoma	3.49e-05	0.00117	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	3.47e-05	0.00117	CbGpPWpGaD
Disopyramide—CYP3A4—Biological oxidations—GSTT1—glaucoma	3.43e-05	0.00115	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—CTSA—glaucoma	3.38e-05	0.00114	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CA1—glaucoma	3.25e-05	0.00109	CbGpPWpGaD
Disopyramide—SCN5A—Axon guidance—MMP9—glaucoma	3.2e-05	0.00108	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—CA2—glaucoma	3.19e-05	0.00107	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CTSA—glaucoma	3.15e-05	0.00106	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	3.07e-05	0.00103	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	3.06e-05	0.00103	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—MMP2—glaucoma	3.04e-05	0.00102	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	3.03e-05	0.00102	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CA1—glaucoma	3e-05	0.00101	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CA2—glaucoma	2.97e-05	0.001	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CTSA—glaucoma	2.91e-05	0.000979	CbGpPWpGaD
Disopyramide—SCN5A—Axon guidance—VEGFA—glaucoma	2.87e-05	0.000966	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CA2—glaucoma	2.75e-05	0.000924	CbGpPWpGaD
Disopyramide—CYP3A4—Biological oxidations—CYP1B1—glaucoma	2.73e-05	0.00092	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—OPN4—glaucoma	2.71e-05	0.000912	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—OPN4—glaucoma	2.7e-05	0.000909	CbGpPWpGaD
Disopyramide—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	2.69e-05	0.000907	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—EDN1—glaucoma	2.68e-05	0.0009	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—OPN4—glaucoma	2.67e-05	0.0009	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—EDN1—glaucoma	2.67e-05	0.000898	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—VEGFA—glaucoma	2.66e-05	0.000894	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—EDN1—glaucoma	2.64e-05	0.000889	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—HEYL—glaucoma	2.52e-05	0.000848	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HEYL—glaucoma	2.51e-05	0.000845	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HEYL—glaucoma	2.49e-05	0.000837	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PTGFR—glaucoma	2.44e-05	0.000821	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PTGFR—glaucoma	2.43e-05	0.000819	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PTGFR—glaucoma	2.41e-05	0.000811	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CA5A—glaucoma	2.4e-05	0.000809	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—NARFL—glaucoma	2.4e-05	0.000809	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—C3—glaucoma	2.34e-05	0.000787	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—C3—glaucoma	2.33e-05	0.000784	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—C3—glaucoma	2.31e-05	0.000777	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—MMP9—glaucoma	2.28e-05	0.000768	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—TNF—glaucoma	2.28e-05	0.000767	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—TXN—glaucoma	2.25e-05	0.000756	CbGpPWpGaD
Disopyramide—CYP3A4—Biological oxidations—GSTM1—glaucoma	2.18e-05	0.000735	CbGpPWpGaD
Disopyramide—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	2.15e-05	0.000725	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—TXN—glaucoma	2.09e-05	0.000705	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—SMO—glaucoma	2.08e-05	0.000701	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—SMO—glaucoma	2.08e-05	0.000699	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—SMO—glaucoma	2.06e-05	0.000692	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—VEGFA—glaucoma	2.05e-05	0.00069	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—TXN—glaucoma	1.93e-05	0.000651	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—RPTOR—glaucoma	1.91e-05	0.000643	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—RPTOR—glaucoma	1.9e-05	0.000641	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—RPTOR—glaucoma	1.88e-05	0.000634	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NCK2—glaucoma	1.85e-05	0.000622	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NCK2—glaucoma	1.84e-05	0.00062	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NCK2—glaucoma	1.82e-05	0.000614	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—TNF—glaucoma	1.76e-05	0.000591	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—GSTT1—glaucoma	1.74e-05	0.000587	CbGpPWpGaD
Disopyramide—CHRM1—Circadian rythm related genes—TP53—glaucoma	1.66e-05	0.000559	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—GSTT1—glaucoma	1.62e-05	0.000547	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—HDAC9—glaucoma	1.57e-05	0.000529	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HDAC9—glaucoma	1.57e-05	0.000527	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HDAC9—glaucoma	1.55e-05	0.000522	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—EDN1—glaucoma	1.51e-05	0.000509	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—EDN1—glaucoma	1.51e-05	0.000507	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GSTT1—glaucoma	1.5e-05	0.000505	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—EDN1—glaucoma	1.49e-05	0.000502	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—ABCA1—glaucoma	1.39e-05	0.000467	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—CYP1B1—glaucoma	1.39e-05	0.000467	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—EDN1—glaucoma	1.37e-05	0.000462	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—EDN1—glaucoma	1.37e-05	0.000461	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—EDN1—glaucoma	1.36e-05	0.000456	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—C3—glaucoma	1.32e-05	0.000445	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—C3—glaucoma	1.32e-05	0.000443	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—C3—glaucoma	1.3e-05	0.000439	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—ABCA1—glaucoma	1.29e-05	0.000436	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CYP1B1—glaucoma	1.29e-05	0.000436	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—SMO—glaucoma	1.23e-05	0.000414	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—SMO—glaucoma	1.23e-05	0.000413	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—SMO—glaucoma	1.21e-05	0.000409	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—C3—glaucoma	1.2e-05	0.000404	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—C3—glaucoma	1.2e-05	0.000402	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CYP1B1—glaucoma	1.2e-05	0.000402	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—ABCA1—glaucoma	1.2e-05	0.000402	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—C3—glaucoma	1.18e-05	0.000399	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CA1—glaucoma	1.17e-05	0.000395	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CTSA—glaucoma	1.14e-05	0.000383	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NTRK2—glaucoma	1.12e-05	0.000379	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NTRK2—glaucoma	1.12e-05	0.000377	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NTRK2—glaucoma	1.11e-05	0.000374	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—GSTM1—glaucoma	1.11e-05	0.000374	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CA2—glaucoma	1.07e-05	0.000361	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—GSTM1—glaucoma	1.03e-05	0.000348	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—MTHFR—glaucoma	9.81e-06	0.00033	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NGFR—glaucoma	9.65e-06	0.000325	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NGFR—glaucoma	9.62e-06	0.000324	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GSTM1—glaucoma	9.56e-06	0.000322	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NGFR—glaucoma	9.53e-06	0.000321	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NTRK1—glaucoma	9.17e-06	0.000309	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—MTHFR—glaucoma	9.14e-06	0.000308	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NTRK1—glaucoma	9.14e-06	0.000308	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—APOE—glaucoma	9.13e-06	0.000307	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NTRK1—glaucoma	9.05e-06	0.000305	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—CAV1—glaucoma	9.05e-06	0.000305	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—APOE—glaucoma	8.51e-06	0.000287	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CDKN2B—glaucoma	8.45e-06	0.000284	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—MTHFR—glaucoma	8.45e-06	0.000284	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CAV1—glaucoma	8.43e-06	0.000284	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CDKN2B—glaucoma	8.42e-06	0.000284	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CDKN2B—glaucoma	8.34e-06	0.000281	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—EDN1—glaucoma	8.11e-06	0.000273	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—EDN1—glaucoma	8.08e-06	0.000272	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—EDN1—glaucoma	8.01e-06	0.000269	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—APOE—glaucoma	7.86e-06	0.000265	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CAV1—glaucoma	7.79e-06	0.000262	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—TXN—glaucoma	7.56e-06	0.000255	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NGF—glaucoma	7.45e-06	0.000251	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NGF—glaucoma	7.43e-06	0.00025	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NGF—glaucoma	7.36e-06	0.000248	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—C3—glaucoma	7.08e-06	0.000238	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—C3—glaucoma	7.06e-06	0.000238	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—C3—glaucoma	6.99e-06	0.000235	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—NOS3—glaucoma	6.84e-06	0.00023	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—APOE—glaucoma	6.6e-06	0.000222	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—APOE—glaucoma	6.57e-06	0.000221	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CAV1—glaucoma	6.53e-06	0.00022	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CAV1—glaucoma	6.51e-06	0.000219	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—APOE—glaucoma	6.51e-06	0.000219	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CAV1—glaucoma	6.45e-06	0.000217	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—NOS3—glaucoma	6.38e-06	0.000215	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PTGS2—glaucoma	6.26e-06	0.000211	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—FN1—glaucoma	6.22e-06	0.000209	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—FN1—glaucoma	6.2e-06	0.000209	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—BAD—glaucoma	6.15e-06	0.000207	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—FN1—glaucoma	6.14e-06	0.000207	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—BAD—glaucoma	6.13e-06	0.000206	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—BAD—glaucoma	6.07e-06	0.000204	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—NOS3—glaucoma	5.89e-06	0.000198	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GSTT1—glaucoma	5.86e-06	0.000197	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PTGS2—glaucoma	5.83e-06	0.000196	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PTGS2—glaucoma	5.39e-06	0.000181	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NOS3—glaucoma	4.94e-06	0.000166	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NOS3—glaucoma	4.93e-06	0.000166	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NOS3—glaucoma	4.88e-06	0.000164	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ABCA1—glaucoma	4.67e-06	0.000157	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CYP1B1—glaucoma	4.67e-06	0.000157	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CDKN1B—glaucoma	4.28e-06	0.000144	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CDKN1B—glaucoma	4.27e-06	0.000144	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CDKN1B—glaucoma	4.23e-06	0.000142	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MMP9—glaucoma	3.96e-06	0.000133	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MMP9—glaucoma	3.95e-06	0.000133	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MMP9—glaucoma	3.91e-06	0.000132	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GSTM1—glaucoma	3.74e-06	0.000126	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—VEGFA—glaucoma	3.56e-06	0.00012	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—VEGFA—glaucoma	3.55e-06	0.000119	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—VEGFA—glaucoma	3.51e-06	0.000118	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—MTHFR—glaucoma	3.3e-06	0.000111	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—APOE—glaucoma	3.07e-06	0.000103	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CAV1—glaucoma	3.05e-06	0.000103	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TP53—glaucoma	2.69e-06	9.05e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TP53—glaucoma	2.68e-06	9.03e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TP53—glaucoma	2.66e-06	8.94e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—NOS3—glaucoma	2.3e-06	7.75e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PTGS2—glaucoma	2.11e-06	7.09e-05	CbGpPWpGaD
